Clinical Trials
23 trialsNCT07589972 2026-05-15
Neoadjuvant Trastuzumab, Pertuzumab Plus Metronomic Vinorelbine for Elderly HER2-Positive Breast Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase NA Not yet recruiting
NCT07570368 2026-05-06
Targeting Stress-Driven Inflammatory and Angiogenic Pathways With Brief ACT to Enhance Neoadjuvant Chemotherapy Response in Locally Advanced Breast Cancer
Universitas Airlangga
Phase NA Not yet recruiting
NCT03978663 2026-02-20
TRIO
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase NA Active not recruiting
NCT07407244 2026-02-17
AKRA
Institute of Oncology Ljubljana
Phase NA Active not recruiting
NCT06739655 2026-02-04
PRADAIIBE
Cancer Research Antwerp
Phase NA Recruiting
NCT00462696 2025-10-06
ISNA-Sein
Institut Bergonié
Phase NA Completed
NCT06876636 2025-07-29
Zoledronic Acid Combined With EC-T for Triple-Negative Breast Cancer
Xijing Hospital
Phase NA Active not recruiting
NCT06190600 2025-04-30
SPORTNATHy
The Greater Poland Cancer Centre
Phase NA Active not recruiting
NCT05992870 2025-03-17
Neoadjuvant Radiotherapy and Immediate Implant-Based Breast Reconstruction
Hubei Cancer Hospital
Phase NA Recruiting
NCT06642428 2025-01-17
Effect of Vitamin D Supplementation on the Efficacy and Adverse Effects of Neoadjuvant Therapy in Patients with Breast Cancer
Affiliated Hospital of Qinghai University
Phase NA Recruiting
NCT06631066 2024-10-08
Effect of Neoadjuvant Chemoradiation on Pathologic Complete Response Rates in Locally Advanced Breast Cancer Patients
National Cancer Institute, Egypt
Phase NA Completed
NCT05216900 2024-06-21
BRENAR
UMC Utrecht
Phase NA Recruiting
NCT06313073 2024-03-15
Neoadjuvant Radiotherapy for Breast Cancer
Changhai Hospital
Phase NA Unknown
NCT02956473 2024-03-12
Supine MRI in Breast Cancer Patients Undergoing Upfront Surgery or Receiving Neoadjuvant Therapy
Dana-Farber Cancer Institute
Phase NA Completed
NCT06080620 2023-10-12
The Choice of Treatment Methods and Efficacy of LABC
Peking Union Medical College Hospital
Phase NA Recruiting
NCT03520894 2019-10-22
ROCK
Azienda Ospedaliero-Universitaria Careggi
Phase NA Unknown
NCT00503841 2019-04-30
Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer
Barbara Ann Karmanos Cancer Institute
Phase NA Terminated
NCT00647218 2017-02-23
Paclitaxel and Radiation Therapy in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer
Vanderbilt-Ingram Cancer Center
Phase NA Completed
NCT01293032 2016-07-12
Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer
Virginia Commonwealth University
Phase NA Completed
NCT00671476 2014-01-10
Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery
National Cancer Institute (NCI)
Phase NA Unknown
NCT00126464 2013-11-06
Fulvestrant or Tamoxifen in Treating Postmenopausal Women Who Are Undergoing Surgery for Ductal Carcinoma in Situ of the Breast
National Cancer Institute (NCI)
Phase NA Unknown
NCT00310089 2013-06-20
AZD2171 and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer
National Cancer Institute (NCI)
Phase NA Completed
NCT00388115 2010-03-29
Radiofrequency Ablation in Treating Patients With Early Invasive Breast Cancer or Ductal Carcinoma in Situ
University of California, Davis
Phase NA Completed